Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bruker : Flexible Molecular Biology Software Solution Combines Cloud with Desktop Functionality to Streamline Workflows and Improve Efficiency

09/02/2021 | 04:12am EDT
BioDrive | Laboratory Data Management
Flexible Molecular Biology Software Solution Combines Cloud with Desktop Functionality to Streamline Workflows and Improve Efficiency
Researchers can now centralize and track chemistry, biology, and molecular biology data and experimental processes within one platform, eliminating data silos and improving data management and retrieval.

BILLERICA, Massachusetts - September 2, 2021: Arxspan, a division of Bruker, announces the launch of BioDrive, a cloud and desktop-based, integrated software solution that allows scientists to advance their molecular biology research. By enabling a seamless workflow across cross-functional teams, BioDrive enables efficient collaboration for researchers, whether users are across the hall or across the globe.

Researchers can now centralize and track chemistry, biology, and molecular biology data and experimental processes within one platform, eliminating data silos and improving data management and retrieval. With its unique dual cloud-based and desktop capabilities, users can perform tasks within BioDrive, which can be integrated into the Arxspan electronic laboratory notebook (ELN).

A user can import molecular biological data from external databases to then annotate, edit, insert nucleic acid sequence data, find restriction enzyme digestion sites and optimize primer design, autosaving at each stage of the process. Using the enterprise version of BioDrive, sequence-based data is fully encrypted in the secure platform, which is accessible from any browser without the need for time-consuming installation.

Suitable for designing and executing new research projects in the multi-omics fields, the BioDrive enhanced user interface features advanced search capabilities as well as timestamps and author signatures through the ELN to track edits from multiple contributors, generating auditable reporting.

This increased functionality of the Arxspan platform's suite of software solutions facilitates scientists' ability to make better informed decisions through enabling one platform to manage all their scientific data securely with internal and external collaborators; chemistry, biology, and NOW molecular biology. Bruker Arxspan's BioDrive also supports new innovative assays to help streamline the drug discovery and development process.

BioDrive is fully compliant with part 11 of Title 21 of the Code of Federal Regulations (21 CFR Part 11) issued by the Food and Drug Administration (FDA).

To find out more about BioDrive, request a demo, or download a free 30-day trial, please visit our website

Dr. Falko Busse, Bruker BioSpin's Group President

Arxspan's industry-leading products enable scientists to work in collaboration across global, cross-functional teams. Bruker BioSpin is widely regarded as a leader in analytical instrumentation, and we are rapidly evolving our digital capabilities to support the scientific community. Arxspan's BioDrive represents an important step in our vision for a digital future.

Peter Rosati, CEO and Founder of Arxspan

Arxspan's vision is to deliver cloud-based scientific informatics tools to customers across the globe. Our acquisition by Bruker in 2019 has brought our vision to life and, with the release of the new BioDrive molecular biology software, we can continue to deploy world-class platforms, tools, services, and best-in-class support to our community of researchers and scientists. We are known for our extensive and responsive support team, who are available round the clock and across the globe for technical inquiries, troubleshooting, and application support.

About Bruker Corporation

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Customer Contact:

Josh Mann
Head of BBIO Enterprise SaaS Software Sales
T: +1 206-565-5446
E: josh.mann@bruker.com

Media Contact:

Thorsten Thiel, Ph.D.
VP of Group Marketing
Bruker BioSpin
T: +49 721 5161-6500
E: thorsten.thiel@bruker.com


Bruker Corporation published this content on 02 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2021 08:11:02 UTC.

ę Publicnow 2021
10/01BRUKER : NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Pro..
10/01Bruker Corporation Receives Orders for Two 1.1 Ghz NMR Avance Neo Systems from U.S. Aca..
09/27BRUKER : Tony Keller Recognized for Extraordinary Achievements in NMR with the Otto-Stern ..
09/07BRUKER : Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
09/02BRUKER : Flexible Molecular Biology Software Solution Combines Cloud with Desktop Function..
08/31BRUKER CORPORATION : Ex-dividend day for
08/30BRUKER CORPORATION : to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
08/20BRUKER CORP : Change in Directors or Principal Officers (form 8-K)
08/11INSIDER TRENDS : Bruker Insider Sells Shares for Tax Slowing 90-Day Buy Trend
08/11INSIDER TRENDS : Bruker Insider Makes Tax Sale Interrupting 90-Day Buy Trend
More news
Analyst Recommendations on BRUKER CORPORATION
More recommendations
Financials (USD)
Sales 2021 2 366 M - -
Net income 2021 254 M - -
Net Debt 2021 194 M - -
P/E ratio 2021 45,4x
Yield 2021 0,21%
Capitalization 11 663 M 11 663 M -
EV / Sales 2021 5,01x
EV / Sales 2022 4,68x
Nbr of Employees 7 400
Free-Float 58,3%
Duration : Period :
Bruker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRUKER CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 77,23 $
Average target price 84,90 $
Spread / Average Target 9,93%
EPS Revisions
Managers and Directors
Frank H. Laukien Chairman, President & Chief Executive Officer
Gerald N. Herman Chief Financial Officer & Executive Vice President
William Alderman Linton Lead Independent Director
Richard A. Packer Independent Director
Hermann Fritz Requardt Independent Director
Sector and Competitors